Blood cancer trials

Blood cancers are also referred to as hematologic cancers. They begin in tissues such as the bone marrow or in the cells of the immune system. They can include lymphomas and leukemia, as well as other blood cancers.

Different blood cancers may need different approaches to treatment.

Types of blood cancer include:

Lymphoma

Hodgkin Lymphoma
Non-Hodgkin Lymphoma including:
- Burkitt Lymphoma
- Diffuse Large B-cell  Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Richter’s Transformation (RT)
- Small Lymphocytic Lymphoma (SLL)
- Waldenstrom’s  Macroglobulinemia (WM)

Leukemia

Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)

Other blood cancers

Essential Thrombocythemia
Multiple Myeloma

Current clinical trials for blood cancers explore investigational medications including: pembrolizumab, bomedemstat, vibostolimab, nemtabrutinib, zilovertamab vedotin, or favezelimab.

MOCT-Web-TA-Image-Hematologic-2_card size

Lymphoma clinical trials

Lymphoma is the most common type of blood cancer.

View lymphoma trials

MOCT-Web-TA-Image-Hematologic-1_card size

Leukemia clinical trials

Leukemia is a cancer of the blood cells, and typically starts in blood-forming tissue, such as bone marrow.

View leukemia trials

MOCT-Web-TA-Image-Hematologic-3_card size

Additional blood cancer clinical trials

Outside of the two most common blood cancer categories, leukemia and lymphoma, there are multiple other types of blood cancers that we research.

View additional blood cancer trials

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

You can also call our clinical trial information center at 1-888-577-8839 to learn more.